Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution Is Supporting Development Across The Asthma Disease Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Asthma Disease Market Compare Between 2026 And 2030?

The asthma disease market has seen significant growth in recent years. It is anticipated to expand from $25.93 billion in 2025 to $27.29 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. The expansion observed in the past can be ascribed to elements like limited awareness concerning asthma management, a reliance on rescue medications, the absence of advanced biologics, insufficient homecare infrastructure, and rising levels of urban pollution.

The asthma disease market is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $33.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected increase during the forecast period is primarily driven by the introduction of new biologics and combined therapies, a rise in the uptake of controller medications, the broadening availability of specialized clinics and home-based care services, enhanced patient awareness through educational initiatives, and the incorporation of digital health monitoring alongside smart inhaler technologies. Key developments expected in the forecast timeframe encompass a global surge in asthma prevalence, a greater embrace of inhalation-based treatments, advancements in biologic and targeted therapeutic options, the proliferation of homecare and specialized clinic facilities, and an emphasis on tailored and precise medical strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25701&type=smp

What Key Growth Drivers Are Influencing The Asthma Disease Market?

The increasing incidence of respiratory ailments is expected to drive the expansion of the asthma disease market. Respiratory disorders encompass various conditions that affect the lungs and breathing process, including chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. The growing occurrence of these disorders stems from particulate matter and nitrogen oxides irritating and inflaming the airways, which results in breathing difficulties and the exacerbation of conditions like asthma. Such diseases can lead to inflammation and structural changes in the airways, thereby triggering or worsening asthma symptoms. For example, in December 2023, the National Library of Medicine, a US-based national library, reported that by 2050, cases of chronic obstructive pulmonary disease (COPD) in low- and middle-income countries are forecast to more than double those in high-income countries. Additionally, sub-Saharan Africa is anticipated to experience a 59% increase and emerge as the global leader in COPD prevalence and cases by 2040. Hence, the rising prevalence of respiratory disorders is a significant factor propelling the growth of the asthma disease market.

What Segment Types Are Included In The Asthma Disease Market Analysis?

The asthma disease market covered in this report is segmented –

1) By Treatment Type: Controller Medications, Rescue Medications, Biologics, Combination Therapy

2) By Cause Of Asthma: Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma

3) By Severity: Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent

4) By Route Of Administration: Oral, Inhaled, Intravenous, Other Route Of Administration

5) By End-Users: Hospitals, Homecare, Specialty Clinics , Other End-Users

Subsegments:

1) By Controller Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines

2) By Rescue Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics

3) By Biologics: Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy

4) By Combination Therapy: ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations

Which Trends Are Contributing To Changes In The Asthma Disease Market?

Leading companies in the asthma disease market are increasingly adopting advanced solutions like integrated Bluetooth-enabled sensor inhalers to improve medication adherence, allow for real-time usage monitoring, and facilitate personalized disease management. These integrated Bluetooth-enabled sensor inhalers are devices fitted with digital sensors that transmit usage information to a smartphone application. They assist individuals with asthma by tracking medication use, enhancing adherence through reminders, and providing data that supports improved symptom monitoring and management. For instance, in July 2023, Teva Pharmaceutical Industries Limited, an Israel-based pharmaceutical company, launched the GoResp Digihaler (budesonide and formoterol) in the UK. This was introduced as the first fully integrated digital inhaler system for asthma disease and chronic obstructive pulmonary disease in Europe. Manufactured in Ireland, this inhaler features built-in sensors that detect and record inspiratory flow and usage quality. It connects with a patient-facing app that displays inhalation performance categorized as good, fair, or low or no, and allows for report sharing with healthcare professionals via email or a clinician dashboard. The application also offers medication reminders to help patients maintain consistency with therapy, while clinicians gain deeper insights into individual technique and adherence patterns, enabling more tailored interventions.

Which Companies Are Influencing The Asthma Disease Market?

Major companies operating in the asthma disease market are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Cipla Limited

Access The Complete Asthma Disease Market Report:

https://www.thebusinessresearchcompany.com/report/asthma-disease-global-market-report

Which Region Contributes The Most To The Asthma Disease Market?

North America was the largest region in the asthma disease market in 2025. The regions covered in the asthma disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Asthma Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=25701&type=smp

Browse Through More Reports Similar to the Global Asthma Disease Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795